§ Funding Round
Series C funding round for HotSpot Therapeutics raising $100M in November 2021
Series C funding round for HotSpot Therapeutics raising $100M in November 2021
| Investor | Firm Type | Partner |
|---|---|---|
AbbVie Ventures | — | — |
Access Biotechnology | — | — |
| Organization | — | |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Samsara BioCapital | — | — |
| Organization | — | |
SR One | — | — |
| Organization | — | |
| Organization | — | |
Fouad Azzam, Ph.D. | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$210M
Top Valuation
-
HotSpot Therapeutics raised $100M in a Series C round.
The round was announced on 11/01/21.
The round was led by Pivotal bioVenture Partners.
